Robotically assisted PCI with CorPath 200 system: early evidence of potential benefits for patient and physician




Background


Robotic PCI has a potential to decrease radiation exposure and contrast fluid usage and increase technical precision. The CorPath 200 System (Corindus, Natick, MA, USA) is a vascular robotic system that drives guidewires and stent/balloon catheters during PCI. It is comprised of the bedside unit and the interventional cockpit. The bedside unit consists of an articulated arm, robotic drive and a cassette. The radiation-shielded interventional cockpit houses a control console and video monitors with duplicate images of the catheterization lab monitors. The PCI devices are controlled by a physician via guidewire and catheter joysticks and/or touchscreen from a control console.




Methods


Two studies — one animal and one clinical — were conducted recently where investigators looked at radiation exposure, contrast volume, procedure and X-ray times. The animal study assessed safety and technical efficacy of the three-vessel robotic PCI and compared it to the manual delivery in acute and chronic swine. The clinical study was designed to assess safety and technical efficacy of the robotic PCI in patients with simple de novo lesions.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Robotically assisted PCI with CorPath 200 system: early evidence of potential benefits for patient and physician

Full access? Get Clinical Tree

Get Clinical Tree app for offline access